Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix

Genes Chromosomes and Cancer

Volumn 26, Issue 4, 1999, Pages 346-354

  Kersemaekers, Anne Marie F ^a   Van De Vijver, Marc J ^a   Kenter, Gemma G ^a   Fleuren, Gert Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; GENE EXPRESSION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MIDDLE AGED; ONCOGENE PROTEINS V-ERBB; PAPILLOMAVIRIDAE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMA VIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0032755950     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199912)26:4<346::AID-GCC9>3.0.CO;2-D     Document Type: Article

References (48)

1. Abeln ECA, Corver WE, Kuipers-Dijkshoorn NJ, Fleuren GJ, Cornelisse CJ. 1994. Molecular genetic analysis of flow-sorted ovarian tumor cells: improved detection of loss of heterozygosity. Br J Cancer 70:255-262.
2. Akasofu M, Oda Y. 1995. Immunohistochemical detection of TP53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18. Virchows Archiv 425:593-602.
3. Atkin NB. 1997. Cytogenetics of carcinoma of the cervix uteri: a review. Cancer Genet Cytogenet 95:33-39.
4. Auvinen E, Crusius K, Steuer B, Alonso A. 1997. Human papillomavirus type 16 E5 protein. Int J Oncol 11:1297-1304.
5. Bauer HM, Greer CE, Manos MM. 1992. Determination of genital human papillomavirus infection by consensus PCR amplification. In Herrington CS, McGee JO, editors. Diagnostic molecular pathology: a practical approach. Oxford: Oxford University Press, p 131-152.
6. Bethwaite PB, Koreth J, Herrington CS, McGee JO. 1995. Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma. Br J Cancer 71:814-818.
7. Bulten J, Poddighe PJ, Robben JCM, Gemmink JH, de Wilde PCM, Hanselaar AGJM. 1998. Interphase cytogenetic analysis of cervical intraepithelial neoplasia. Am J Pathol 152:495-503.
8. Cattoretti G, Pileri S, Parravicini C, Becker MHG, Poggi S, Bifulco C, Key G, D'Amato L, Sabattini E, Feudale E, Reynolds F, Gerdes J, Rilke F. 1993. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171:83-98.
9. Cavuslu S, Goodlad J, Hobbs C, Connor AM, Shanti Raju K, Best JM, Cason J. 1997. Relationship between human papillomavirus infection and overexpression of TP53 protein in cervical carcinomas and lymph node metastases. J Med Virol 53:111-117.
10. Chung GTY, Huang DP, Wai Lo K, Chan MKM, Wong FWS. 1992. Genetic lesion in the carcinogenesis of cervical cancer. Anticancer Res 12:1485-1490.
11. Costa MJ, Walls J, Trelford JD. 1995. C-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. Am J Clin Pathol 104:634-642.
12. Crusius K, Auvinen E, Alonso A. 1997. Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein. Oncogene 15:1437-1444.
13. Dam PA van, Lowe DG, Watson JY, James M, Chard T, Hudson CN, Shepherd JH. 1991. Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tract. Gynecol Oncol 42:256-264.
14. Devilee P, Schothorst EM, Bardoel AFJ, Bonsing BA, Kuipers-Dijkshnorn NJ, James MR, Fleuren GJ, van der Mey AGL, Cornelisse CJ. 1994. Allelotype of head and neck paragangliomas: allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL. Genes Chromosomes Cancer 11:71-78.
15. Evans MF, Koreth J, Bakkenist CJ, Herrington CS, McGee JO. 1998. Allelic deletion at 11q23.3-q25 is an early event in cervical neoplasia. Oncogene 16:2557-2564.
16. Greer CE, Peterson SL, Kiviat NB, Manos MM. 1991. PCR amplification from paraffin-embedded tissues: effects of fixative and fixation time. Am J Clin Pathol 95:117-124.
17. Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle RMC, Williams AWR, Steel CM, Bird CC, Stanbridge EJ, Evans GA. 1994. Loss of heterozygosity in cervical carcinoma: subchromosornal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 91:6953-6957.
18. Hampton GM, Larson AA, Baergen RN, Sommers RL, Kern S, Cavenee WK. 1996. Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci USA 93:6704-6709.
19. Hunt CR, Hale RJ, Buckley CH, Hunt J. 1996. TP53 expression in carcinoma of the cervix. J Clin Pathol 49:971-974.
20. Jeffers MD, Richmond J, Farquharson M, McNicol AM. 1994. TP53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium. J Clin Pathol 47:1073-1076.
21. Kersemaekers AMF, Hermans J, Fleuren GJ, van de Vijver MJ. 1998. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinoma of the uterine cervix. Br J Cancer 77:192-200.
22. Kihana T, Tsuda H, Teshima S, Nomoto K, Tsugane S, Sonoda T, Matsuura S, Hirohashi S. 1994. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix. Cancer 73:148-153.
23. Kim JW, Kim YT, Kim DK, Song CH, Lee JW. 1996. Expression of epidermal growth factor receptor in carcinoma of the cervix. Gynecol Oncol 60:283-287.
24. Kisseljov F, Semionova L, Samoylova E, Mazurenko N, Komissarova E, Zourbitskaya V, Gritzko T, Kozachenko V, Netchushkin M, Petrov S, Smirnov A, Alonso A. 1996. Instability of chromosome 6 microsatellite repeats in human cervical tumors carrying papilloma-virus sequences. Int J Cancer 69:484-487.
25. Kristensen GB, Holm R, Abeler VM, Trope CG. 1996. Evaluation of the prognosic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. Cancer 78:433-440.
26. Kurvinen K, Syrjanen K, Syrjanen S. 1996. TP53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions. J Clin Oncol 14:2120-2130.
27. Larson AA, Liao SY, Stanbridge EJ, Cavenee WK, Hampton GM. 1997. Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Res 57:4171-4176.
28. Mandai M, Konishi I, Koshiyama M, Komatsu T, Yamamoto S, Nanbu K, Mori T, Fukumoto M. 1995. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix. Cancer 75:2523-2529.
29. Manos MM, Wright DK, Lewis AJ, Broker TR, Wolinski SM. 1989. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In Furth M, Greaves M, editors. Molecular, diagnostics of human cancer: cancer cells. Cold Spring Harbor, NY: Cold Spring Harbor Press, p 209-214.
30. Mitra AB, Murty VVVS, Li RG, Pratap M, Luthra UK, Chaganti RSK. 1994. Allelotype analysis of cervical carcinoma. Cancer Res 54:4481-1487.
31. Mitra AB, Murty VVVS, Singh V, Li RG, Pratap M, Sodhani P, Luthra UK, Chaganti RSK. 1995. Genetic alterations at 5p15: a potential marker for progression of precancerous lesions of the uterine cervix. J Natl Cancer Inst 87:742-745.
32. Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Klinger HP. 1996. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res 56:197-205.
33. Oka K, Nakano T, Arai T. 1994. C-erbB-2 oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix. Cancer 73:668-671.
34. Park TW, Fujiwara H. Wright TC. 1995. Molecular biology of cervical cancer and its precursors. Cancer 76:1902-1913.
35. Pfeifer D, Stellwag B, Pfeifer A, Borlinghaus P, Meier W, Scheidel P. 1989. Clinical implications of the epidermal growth factor receptor in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 33:146-150.
36. Pim D, Collins M, Banks L. 1992. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7:27-32.
37. Rader JS, Kamarasova T, Huettner PC, Li L, Li Y, Gerhard DS. 1996. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene 13:2737-2741.
38. Rader JS, Gerhard DS, O'Sullivan MJ, Li Y, Li L, Liapis H, Huettner PC. 1998. Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p. Genes Chromosomes Cancer 22:57-65.
39. Roda-Husman AM, Walboomers JMM, Van den Brule AJC, Meijer CJLM, Snijders PJF. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J General Virol 76:1057-1062.
40. Roz L, Wu CL, Porter S, Scully C, Speight P, Read A, Sloan P, Thakker N. 1996. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res 56:1228-1231.
41. Skopelitou A, Kamina S, Krikoni O, Alexopoulou V, Agnantis NJ. 1997. TP53 DO-1 immunohistochemical overexpression in premalignant and malignant cervical lesions. Anticancer Res 17:269-276.
42. Southern SA, Evans MF, Herrington CS. 1997. Basal cell tetrasomy in low-grade cervical squamous intraepithelial lesions infected with high-risk human papillomaviruses. Cancer Res 57:4210-4213.
43. Sreekantaiah C, Braekeleer M de, Haas O. 1991. Cytogenetic findings in cervical carcinoma. Cancer Genet Cytogenet 53:75-81.
44. Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJM, Vermeer BJ, Jebbink MF, Smits HL. 1993. Detection of cuteneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 42:265-280.
45. Vecchione A, Cermele C, Giovagnoli MR, Valli C, Alimandi M, Carico E, Esposito DL, Mariani-Costantini R, French D. 1994. TP53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix. Gynecol Oncol 55:343-348.
46. Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R. 1988. Neu protein overexpression in breast cancer. N Engl J Med 319:1239-1245.
47. Wistuba II, Montellano FD, Milchgrub S, Virmani AK, Behrens C, Chen H, Ahmadian M, Nowak JA, Muller C, Minna JD, Gazdar AF. 1997. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 57:3154-3158.
48. Zur Hausen H. 1995. Are human papillomavirus infections not necessary of sufficient causal factors for invasive cancer of the cervix? Int J Cancer 63:315-316.